154 related articles for article (PubMed ID: 18459178)
1. Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia.
Kurt B; Flynn P; Shenep JL; Pounds S; Lensing S; Ribeiro RC; Pui CH; Razzouk BI; Rubnitz JE
Cancer; 2008 Jul; 113(2):376-82. PubMed ID: 18459178
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia.
Boztug H; Mühlegger N; Pötschger U; Attarbaschi A; Peters C; Mann G; Dworzak M
Ann Hematol; 2017 Jan; 96(1):99-106. PubMed ID: 27699447
[TBL] [Abstract][Full Text] [Related]
3. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Inaba H; Gaur AH; Cao X; Flynn PM; Pounds SB; Avutu V; Marszal LN; Howard SC; Pui CH; Ribeiro RC; Hayden RT; Rubnitz JE
Cancer; 2014 Jul; 120(13):1985-92. PubMed ID: 24677028
[TBL] [Abstract][Full Text] [Related]
4. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Observational Assessment of the Impact of Cefepime Prophylaxis in Neutropenic Pediatric Patients With Acute Myelogenous Leukemia.
Almatrafi MA; Dassner AM; Aquino V; Slone T; Sebert M
J Pediatric Infect Dis Soc; 2023 Aug; 12(8):471-476. PubMed ID: 37591306
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin versus colistin prophylaxis during neutropenia in acute myeloid leukemia: two parallel patient cohorts treated in a single center.
Pohlen M; Marx J; Mellmann A; Becker K; Mesters RM; Mikesch JH; Schliemann C; Lenz G; Müller-Tidow C; Büchner T; Krug U; Stelljes M; Karch H; Peters G; Gerth HU; Görlich D; Berdel WE
Haematologica; 2016 Oct; 101(10):1208-1215. PubMed ID: 27470601
[TBL] [Abstract][Full Text] [Related]
7. Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis.
Barker GJ; Call SK; Gamis AS
J Pediatr Hematol Oncol; 1995 May; 17(2):151-5. PubMed ID: 7749765
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Yeh TC; Hou JY; Huang TH; Lu CH; Sun FJ; Huang HM; Liu HC
Sci Rep; 2021 Oct; 11(1):21142. PubMed ID: 34707164
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
10. Adverse Effects of Intravenous Vancomycin-Based Prophylaxis during Therapy for Pediatric Acute Myeloid Leukemia.
Sun Y; Huskey RL; Tang L; Inaba H; Gaur AH; Ribeiro R; Rubnitz JE; Wolf J
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29229640
[TBL] [Abstract][Full Text] [Related]
11. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
12. Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
Al Omar S; Anabtawi N; Al Qasem W; Rihani R
J Pediatr Hematol Oncol; 2017 Apr; 39(3):e131-e135. PubMed ID: 28234737
[TBL] [Abstract][Full Text] [Related]
13. Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia.
Okamoto Y; Ribeiro RC; Srivastava DK; Shenep JL; Pui CH; Razzouk BI
J Pediatr Hematol Oncol; 2003 Sep; 25(9):696-703. PubMed ID: 12972804
[TBL] [Abstract][Full Text] [Related]
14. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Rodríguez-Veiga R; Montesinos P; Boluda B; Lorenzo I; Martínez-Cuadrón D; Salavert M; Pemán J; Calvillo P; Cano I; Acuña E; Villalba A; Piñana JL; Sanz J; Solves P; Senent L; Vicente A; Sempere A; Cervera J; Barragán E; Jarque I; Torres A; Sanz MA; Sanz GF
Ann Hematol; 2019 Sep; 98(9):2081-2088. PubMed ID: 31240471
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.
Ghadiany M; Rahimi H; Rezvani H; Mohammad Alizadeh A; Zamani N; Mehdizadeh M; Foratyazdi M
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e11-5. PubMed ID: 24330539
[TBL] [Abstract][Full Text] [Related]
16. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia.
Kern W; Kurrle E; Vanek E
Klin Wochenschr; 1987 Aug; 65(16):773-80. PubMed ID: 3477669
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.
de Jong P; de Jong M; Kuijper E; van der Lelie J
Eur J Clin Microbiol Infect Dis; 1993 Oct; 12(10):750-5. PubMed ID: 8307043
[TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.
Przybylski DJ; Reeves DJ
Support Care Cancer; 2017 Dec; 25(12):3715-3721. PubMed ID: 28660351
[TBL] [Abstract][Full Text] [Related]
19. [Breakthrough of invasive fungal disease with posaconazole as primary prophylaxis after induction chemotherapy for acute myeloid leukemia].
Pei RZ; Lu Y; Zhang PS; Liu XH; Chen D; Du XH; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Tang SH
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):213-217. PubMed ID: 32146748
[No Abstract] [Full Text] [Related]
20. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
